|
|
|
|
 |
Volume 9, Issue 3 (Summer 2021) |
 |
|
|
|
|
Frequency of Psychosomatic Symptoms in Patients with Covid-19
|
Pierhossein Kolivand *   , Zahra Kolivand , Hadi Kazemi , Maryam Kolivand |
| a. Health Economic Department, Shahed University, Tehran, Iran b. Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran , peirhossein@yahoo.com |
|
|
Abstract: (2690 Views) |
| Introduction: Infection with SARS-CoV-2 spread rapidly around the world and is recognized by the World Health Organization as a pandemic. Psychological disorders, such as anxiety, have caused countless problems for societies during the last years. In the present study, various clinical features of patients with COVID-19 disease, particularly psychosomatic symptoms, were investigated. Materials and Methods: Clinical characteristics of 2928 patients with SARS-CoV-2 infection, including risk factors such as diabetes mellitus, hypertension, cardiovascular disease, and chronic kidney disease as well as anxiety were collected in different cities in Iran (Tehran, Karaj, Hamedan, and Kermanshah) and analyzed. Results: Our data have shown different patterns of clinical features and anxiety rates in patients with COVID-19 in various regions of Iran. However, the characteristics of chronic inflammatory lung disease were similar in these patients in various areas. Conclusion: Geographical factors, as well as the medical facilities of the participants, may affect the clinical features of patients with COVID-19 disease. |
|
| Keywords: Clinical Characteristics, COVID-19, Coronavirus, Pandemic |
|
|
Full-Text [PDF 1411 kb]
(1335 Downloads)
|
|
Type of Study: Research --- Open Access, CC-BY-NC |
Subject:
Psycology
|
|
|
|
|
|
|
| References |
1. Crocq MA. A history of anxiety: from Hippocrates to DSM. Dialogues Clin Neurosci. 2015 Sep;17(3): 319-25. [ DOI:10.31887/DCNS.2015.17.3/macrocq] 2. Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015 Jun;16(6):317-31. [ DOI:10.1038/nrn3945] 3. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014 Sep;23(133):345-9. [ DOI:10.1183/09059180.00007813] 4. Tully, P.J., Harrison, N.J., Cheung, P. Anxiety and Cardiovascular Disease Risk: a Review. Curr Cardiol Rep 18, 120 (2016). [ DOI:10.1007/s11886-016-0800-3] 5. 5 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. [ DOI:10.1016/S0140-6736(20)30183-5] 6. Surveillances V. The epidemiological characteristics of an out break of 2019 novel Coronavirus Diseases (COVID-19)-China.China CDC Weekly. 2020; 2(8):113-22. [ DOI:10.46234/ccdcw2020.032] 7. Abdolahi S, Gorji A. COVID-19: The potential role of nutritional deficiencies, global climatic changes, and immune system dysfunction. Iranian Journal of War and Public Health. 2020 Nov 10;12(4): 249-258. [ DOI:10.52547/ijwph.12.4.249] 8. Chan JF-W, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. Afamilial cluster of pneumonia associated with the 2019 novel Coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet. 2020; 395(10223): 514-23. [ DOI:10.1016/S0140-6736(20)30154-9] 9. Dong X, Cao Y-Y, Lu X-X. Eleven faces of coronavirus disease 2019. Allergy. 2020; 75: 1699- 709. [ DOI:10.1111/all.14289] 10. Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P, et al. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. JCR 2020: 1-29. [ DOI:10.1007/s11357-020-00198-w] 11. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association be-tween COVID-19 mortality and health-care resource availability. The Lancet Global Health. 2020; 8(4):e480. [ DOI:10.1016/S2214-109X(20)30068-1] 12. Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: A meta-analysis. Epidemiology & Infection. 2020; 148: e175. [ DOI:10.1017/S095026882000179X] 13. Rahman A, Sathi NJ. Risk factors of the severity of COVID‐19:A meta‐analysis. International Journal of Clinical Practice. 2020; e13916. [ DOI:10.1101/2020.04.30.20086744] 14. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20): 2052-9. [ DOI:10.1001/jama.2020.6775] 15. Fortin M, Lapointe L, Hudon C, Vanasse A. Multimorbidity is common to family practice: Is it commonly researched? Canadian Family Physician. 2005; 51(2): 244-5. 16. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wit- tenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity. Diabetes Care. 2007; 30(9): 2222-7. [ DOI:10.2337/dc07-0158] 17. Salari-Moghaddam S, Ranjbar A, Fathi-Ashtiani A. Validity and Reliability measurement of the Persian version of anxiety Control Questionnaire. Journal of Clinical Psychology, 2018; 9(4): 33-43.
|
|
|
|
|
|
|
|
|
